Table 1.
Resection (n = 60) | Biopsy (n = 45) | P-value | |
---|---|---|---|
Median age/y | 59 (17–76) | 64 (29–89) | P = .004 |
Gender(male/female) | 30/30 | 27/18 | P = .309 |
Median KPS | 70(30–90) | 70(30–100) | P = .040 |
Maximum dimension | |||
< 3 cm | 11(19.0%) | 16(36.4%) | P = .084 |
≥ 3 cm | 40(69.0%) | 27(61.4%) | |
Location | |||
Deep | 23(38.3%) | 34(75.6%) | P < 0.001 |
Superficial | 37(61.7%) | 11(24.4%) | |
Radiation therapy | |||
Yes | 33(55.0%) | 21(46.7%) | P = .239 |
No | 18(30.0%) | 19(42.2%) | |
Chemotherapy | |||
Yes | 32(53.3%) | 34(75.6%) | P = .002 |
No | 14(23.3%) | 1(2.2%) | |
Median PFS/m | 29.27 | 44.03 | P = .567 |
Median OS/m | 64.17 | 59.93 | P = .883 |
Survival rate | 46.7% | 55.6% | P = .367 |
Abbreviation: PFS, progression-free survival, OS overall survival, KPS Karnofsky performance status;